Active Surveillance of the Small Renal Mass: An Integrated Biomarker Trial

What is the purpose of this trial?


Active surveillance in kidney cancer involves closely observing the tumor with periodic imaging studies rather than immediately proceeding to an invasive treatment. This does not mean that the tumor is ignored or that future treatment is not necessary, rather it means the tumor does not require treatment at this time. On active surveillance, a tumor is closely monitored without treatment, however if the tumor changes and reaches a predefined threshold that your physician no longer considers safe, your physician will strongly encourage treatment.


Participation Guidelines

Age: Any

Click here for detailed participation information for this trial.

Sponsor: Yale University School of Medicine
Dates:
Last Updated:
Study HIC#: 1312013110